Pfizer is preparing to apply for an emergency use authorization from the Food and Drug Administration for its coronavirus vaccine. The drug company said that the final analysis from their Phase 3 Clinical trial found that the vaccine is 95% effective and has no serious side effects. “The study results mark an important step in this historic eight-month journey to bring forward...
Read Full StoryTop News
Related
, 6min
0
Team of researchers and educators support an effort to boost sea urchin farming in New England
, 6min
0
Florida, America's COVID-Filled Armpit, Has Offered To Host The Olympics If Japan Pulls Out
, 7min
0